UGA Biopharma GmbH

UGA Biopharma GmbH is a research and development organization founded in 2009 in Hennigsdorf near Berlin, specializing in developing monoclonal cell lines to produce biologics and biosimilars. UGA Biopharma supports customers across the entire development value chain, from cell line development to purification and analytical method development, also offering ready-to-use (R2U) cell lines for expressing biosimilar candidates as well as its proprietary CHO Prime media and feeds platform for cell culture applications.